This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Davies, M. J Search for Related Content Social Bookmarking                         What's this?

A National Service Framework for diabetes

Departments of Diabetes, Endocrinology and Cardiovascular Medicine, Leicester Royal Infirmary, Leicester, MDavies{at}uhl.trent.nhs.uk

References

• Department of Health. National Service Framework for coronary heart disease. London The Stationary Office 2000.
• Panzram G. Mortality and survival in type 2 diabetes. Diabetologia 1987;30:123-31.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wood D., Durrington P., Poulter N., McInnes G., Ree A., Wray R on behalf of British Cardiac Society, British Hyperlipidemia Association, British Hypertension Society and British Diabetic Association. Joint British Recommendations on prevention on coronary heart disease in clinical practice. Heart 1998;80(suppl 2):S1-S29.[Free Full Text]
• The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival study Lancet 1994;344:1383-9.
• Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Med 1997;14(suppl 5):S7-S85.[CrossRef][Web of Science]
• The Audit Commission. Testing Times: a review of diabetes services in England and Wales 2000.
• Winocour PH, Ainsworth A., Williams R. Survey of secondary care services for diabetics in the United Kingdom 2000. 1: Methodology and Major Findings.
• Association of British Clinical Diabetologists (ABCD) A survey of consultant-led services. Summary Results. Nov 2000.
• Vaughan NJA for the Diabetes Audit Working Group of the Research Unit of the Royal College of Physicians and the British Diabetic Association. The UK diabetes dataset; a standard for information exchange. Diabetic Med 1995;12:717-22.[Web of Science][Medline] [Order article via Infotrieve]
• Roxborgh M. UKDIABS Annual Report. Research Department Diabetes UK. March 2001.
• Bailey CJ The Diabetes Prevention Program: headline results. Br J Diabetes Vasc Dis 2001;1:62-4.[Abstract/Free Full Text]
• Tuomilehto J., Lindstrom J., Erikksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.[Abstract/Free Full Text]
• The Diabetes Group and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977-86.[Abstract/Free Full Text]
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes UKPDS 38. BMJ 1998;317:703-13.[Abstract/Free Full Text]
• Sanmugunathan PS, Ghahramani P., Jackson PR et al. Aspirin for primary prevention of coronary heart disease; safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart 2000;85:265-71.[CrossRef][Web of Science]
• Currie CJ, Kraus D., Morgan CL, Gill L., Stott NC, Peters JR NHS acute sector expenditure of diabetes. The present, the future and excess inpatient costs of care. Diabetic Med 1997;14:686-92.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Alberti Kgmm, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1:diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Med 1998;15:539-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wareham NJ, Griffin SJ Should we screen for type 2 diabetes? Evaluation against National Screening Committee. BMJ 2001;322:986-8.[Free Full Text]

The British Journal of Diabetes & Vascular Disease, Vol. 1, No. 2, 123-125 (2001)
DOI: 10.1177/14746514010010021101


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. G Buckley, S. N Liversedge, and J. D Dean Diabetes services in primary care: are we prepared for the diabetes NSF? The British Journal of Diabetes & Vascular Disease, November 1, 2003; 3(6): 418 - 423. [Abstract] [PDF]

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Davies, M. J Search for Related Content Social Bookmarking                         What's this?